Radioiodine for thyroid cancer: sometimes, less is best
AUTOR(ES)
Padovani, Rosalia do Prado
FONTE
Arch. Endocrinol. Metab.
DATA DE PUBLICAÇÃO
2016-02
RESUMO
Documentos Relacionados
- Advanced cancer: aiming for the best in care.
- Advanced cancer: aiming for the best in care
- Peptide receptor radionuclide therapy (PRRT) in radioiodine-refractory thyroid cancer: A case report of significant response to lu177 DOTA-TATE treatment
- Peptide receptor radionuclide therapy (PRRT) in radioiodine-refractory thyroid cancer: A case report of significant response to lu177 DOTA-TATE treatment
- Radiation exposure and thyroid cancer: a review